{
 "name": "長佳智能",
 "slug": "tw-6841",
 "aliases": [
  "長佳智能股份有限公司",
  "EFAI",
  "6841"
 ],
 "ticker": "6841",
 "industry": "生技醫療業",
 "website": "https://www.everfortuneai.com.tw/",
 "summary": "長佳智能（6841）是上櫃的生技醫療類股公司，2018 年成立，2023 年上櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "長佳智能股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "英文簡稱",
   "value": "EFAI",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心上櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "上櫃日期",
   "value": "2023-03-01",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "成立日期",
   "value": "2018-06-28",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "董事長",
   "value": "陳明豐",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "總經理",
   "value": "李友錚",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "實收資本額",
   "value": 952230000,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "安永聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "公司網址",
   "value": "https://www.everfortuneai.com.tw/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 36957,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源不符合本次白名單；回查官方115年09月營收申報，claim/value/unit/as_of保留，僅更正輸出複本source。核對列與原來源保存在research/basic_source_corrections.json。"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": 65.34,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源不符合本次白名單；回查官方115年09月營收申報，claim/value/unit/as_of保留，僅更正輸出複本source。核對列與原來源保存在research/basic_source_corrections.json。"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": 18.17,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源不符合本次白名單；回查官方115年09月營收申報，claim/value/unit/as_of保留，僅更正輸出複本source。核對列與原來源保存在research/basic_source_corrections.json。"
  },
  {
   "claim": "產品許可：EFAI Intelligent Cardiothoracic Ratio（iCTR）Assessment System",
   "value": "FDA 510(k) K212624｜美國｜2022-04-04",
   "unit": "",
   "as_of": "2022-04-04",
   "source": "https://www.accessdata.fda.gov/cdrh_docs/pdf21/K212624.pdf",
   "note": "FDA實質等同性上市許可（clearance），不是PMA新藥／醫材核准；採FDA信函日期，不採公司翌日公告或收件日。"
  },
  {
   "claim": "產品許可：EFAI ChestSuite XR Pneumothorax Assessment System",
   "value": "FDA 510(k) K221552｜美國｜2022-11-08",
   "unit": "",
   "as_of": "2022-11-08",
   "source": "https://www.accessdata.fda.gov/cdrh_docs/pdf22/K221552.pdf",
   "note": "FDA實質等同性上市許可（clearance），不是PMA新藥／醫材核准；採FDA信函日期，不採公司翌日公告或收件日。"
  },
  {
   "claim": "產品許可：EFAI ChestSuite XR Malpositioned ETT Assessment System（ETT-XR-100）",
   "value": "FDA 510(k) K242821｜美國｜2025-02-20",
   "unit": "",
   "as_of": "2025-02-20",
   "source": "https://www.accessdata.fda.gov/cdrh_docs/pdf24/K242821.pdf",
   "note": "FDA實質等同性上市許可（clearance），不是PMA新藥／醫材核准；採FDA信函日期，不採公司翌日公告或收件日。"
  },
  {
   "claim": "產品許可：Seg Pro V3（RT-300）",
   "value": "FDA 510(k) K251306｜美國｜2026-01-28",
   "unit": "",
   "as_of": "2026-01-28",
   "source": "https://www.accessdata.fda.gov/cdrh_docs/pdf25/K251306.pdf",
   "note": "FDA實質等同性上市許可（clearance），不是PMA新藥／醫材核准；採FDA信函日期，不採公司翌日公告或收件日。"
  },
  {
   "claim": "產品許可：EFAI ERSuite CT Appendicitis Assessment System（APPEN-CT-100）",
   "value": "FDA 510(k) K253163｜美國｜2026-04-22",
   "unit": "",
   "as_of": "2026-04-22",
   "source": "https://www.accessdata.fda.gov/cdrh_docs/pdf25/K253163.pdf",
   "note": "FDA實質等同性上市許可（clearance），不是PMA新藥／醫材核准；採FDA信函日期，不採公司翌日公告或收件日。"
  },
  {
   "claim": "管線：EFAI BoneSuite XR Bone Age Pro Assessment System",
   "value": "2至16歲左手X光骨齡輔助評估｜已接獲TFDA醫療器材許可證核准通知｜台灣",
   "unit": "",
   "as_of": "2024-12-24",
   "source": "https://mopsov.twse.com.tw/mops/web/ajax_t05st01?firstin=true&step=2&co_id=6841&spoke_date=20241224&spoke_time=164829&seq_no=1&TYPEK=otc",
   "note": "發言日期2024-12-24 16:48:29；主旨：本公司「EFAI BONESUITE XR BONE AGE PRO ASSESSMENT SYSTEM」獲得衛生福利部食品藥物管理署(TFDA)醫療器材許可證核准通知；序號1。公告所列證號008263；公司核准通知日與主管機關落款日未混用。"
  },
  {
   "claim": "管線：EFAI NeuroSuite CT Midline Shift Assessment System",
   "value": "疑似腦中線偏移影像優先分流｜已接獲TFDA醫療器材許可證核准通知｜台灣",
   "unit": "",
   "as_of": "2025-03-27",
   "source": "https://mopsov.twse.com.tw/mops/web/ajax_t05st01?firstin=true&step=2&co_id=6841&spoke_date=20250327&spoke_time=150136&seq_no=2&TYPEK=otc",
   "note": "發言日期2025-03-27 15:01:36；主旨：本公司「EFAI NEUROSUITE CT MIDLINE SHIFT ASSESSMENTSYSTEM」獲得衛生福利部食品藥物管理署(TFDA)醫療器材許可證核准通知；序號2。公告所列證號008452；公司核准通知日與主管機關落款日未混用。"
  },
  {
   "claim": "管線：EFAI ChestSuite XR Malpositioned ETT Assessment System",
   "value": "胸部X光氣管內管垂直錯位分流與通知｜已接獲TFDA醫療器材許可證核准通知｜台灣",
   "unit": "",
   "as_of": "2025-04-24",
   "source": "https://mopsov.twse.com.tw/mops/web/ajax_t05st01?firstin=true&step=2&co_id=6841&spoke_date=20250424&spoke_time=174649&seq_no=2&TYPEK=otc",
   "note": "發言日期2025-04-24 17:46:49；主旨：本公司「EFAI CHESTSUITE XR MALPOSITIONED ETTASSESSMENT SYSTEM」獲得衛生福利部食品藥物管理署(TFDA)醫療器材許可證核准通知。；序號2。公告所列證號008157；公司核准通知日與主管機關落款日未混用。"
  },
  {
   "claim": "管線：EFAI Smart Software for Assisting Anti-Microbial Resistance Detection",
   "value": "金黃色葡萄球菌質譜訊號之MRSA抗藥性輔助推論｜已接獲TFDA醫療器材許可證核准通知｜台灣",
   "unit": "",
   "as_of": "2025-04-28",
   "source": "https://mopsov.twse.com.tw/mops/web/ajax_t05st01?firstin=true&step=2&co_id=6841&spoke_date=20250428&spoke_time=155818&seq_no=2&TYPEK=otc",
   "note": "發言日期2025-04-28 15:58:18；主旨：本公司「EFAI Smart Software for AssistingAnti-Microbial Resistance Detection」獲得衛生福利部食品藥物管理署(TFDA)醫療器材許可證核准通知。；序號2。公告所列證號008372；公司核准通知日與主管機關落款日未混用。"
  },
  {
   "claim": "管線：EFAI TRODAT-1 dopamine transporter scan平台",
   "value": "20歲以上TRODAT-1掃描紋狀體多巴胺轉運體攝取輔助評估｜已接獲TFDA醫療器材許可證核准通知｜台灣",
   "unit": "",
   "as_of": "2025-12-21",
   "source": "https://mopsov.twse.com.tw/mops/web/ajax_t05st01?firstin=true&step=2&co_id=6841&spoke_date=20251221&spoke_time=202328&seq_no=1&TYPEK=otc",
   "note": "發言日期2025-12-21 20:23:28；主旨：本公司「腦部多巴胺轉運體斷層掃描電腦輔助偵測平台」獲得衛福部食品藥物管理署(TFDA)醫療器材許可證核准通知；序號1。公告所列證號衛部醫器製字第008161號；公司核准通知日與主管機關落款日未混用。"
  },
  {
   "claim": "管線：Seg Pro V3",
   "value": "18歲以上癌症CT或MR影像之危及器官初步勾勒｜已接獲TFDA醫療器材許可證核准通知｜台灣",
   "unit": "",
   "as_of": "2025-12-21",
   "source": "https://mopsov.twse.com.tw/mops/web/ajax_t05st01?firstin=true&step=2&co_id=6841&spoke_date=20251221&spoke_time=202358&seq_no=2&TYPEK=otc",
   "note": "發言日期2025-12-21 20:23:58；主旨：本公司「放射治療器官自動勾勒系統 (Seg Pro V3)獲得衛生福利部食品藥物管理署(TFDA)醫療器材許可證核准通知；序號2。公告所列證號衛部醫器製字第008577號；公司核准通知日與主管機關落款日未混用。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-6841.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}